Response to Letter to the Editor: “Efficacy and Safety of Combination Therapy With Low Dose of Telmisartan and S-Amlodipine in Patients With Hypertension: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial”

Key Points

• This research focuses on evaluating the efficacy and safety of a combination therapy using low doses of telmisartan and s-amlodipine in patients with hypertension.
• Randomized double-blind multicenter phase III clinical trial
• Participants received combination therapy with low doses of telmisartan and s-amlodipine
• Study assessed efficacy and safety outcomes over a specified duration.
• Combination therapy significantly reduced blood pressure compared to baseline (exact values not specified)
• Safety profile of the combination was favorable with minimal adverse effects reported
• Efficacy demonstrated improvement in overall hypertension management.